Cancer Research· 2014Q1
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- 7,276citations
- Q1SCImago
- 2014year
Short summary
By 2030, thyroid cancer will become the fourth leading cancer diagnosis in the US, surpassing colorectal cancer, while pancreas and liver cancers will become the second and third leading causes of cancer death, respectively.
AI-generated from the title and abstract; the full text is not read.
Key points
- Thyroid cancer is projected to become the fourth leading cancer diagnosis in the US by 2030, replacing colorectal cancer.
- Pancreas and liver cancers are projected to become the second and third leading causes of cancer-related death by 2030, respectively.
- Lung cancer is expected to remain the top cancer killer throughout the projection period.
- Breast, prostate, and lung cancers will continue to be the top cancer diagnoses.
AI-generated from the title and abstract; the full text is not read.
Abstract
Cancer incidence and deaths in the United States were projected for the most common cancer types for the years 2020 and 2030 based on changing demographics and the average annual percentage changes in incidence and death rates. Breast, prostate, and lung cancers will remain the top cancer diagnoses throughout this time, but thyroid cancer will replace colorectal cancer as the fourth leading cancer diagnosis by 2030, and melanoma and uterine cancer will become the fifth and sixth most common cancers, respectively. Lung cancer is projected to remain the top cancer killer throughout this time period. However, pancreas and liver cancers are projected to surpass breast, prostate, and colorectal cancers to become the second and third leading causes of cancer-related death by 2030, respectively. Advances in screening, prevention, and treatment can change cancer incidence and/or death rates, but it will require a concerted effort by the research and healthcare communities now to effect a substantial change for the future.
The authors' abstract, as published at the source. Cancer Research, 2014 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Oncology
OncologyMedicine